What a pharmacist should know about drug interactions and adverse effects of cardiovasculary therapy
Abstract
In the long term, cardiovascular diseases represent the main cause of morbidity and mortality of adult population in the Czech Republic. Concerning the numbers of distributed unit packs by ATC groups, cardiovascular therapeutics are the most voluminous group, constituting 20.36% of total (1).
Drug interaction are a serious cause of toxicity and of adverse effects of all used drugs. Their recognition is often problematic in the context of differential diagnosis.
The occurrence of adverse effects of therapy depends on quantity of simultaneously dosed drugs. With increasing quantity of drugs grows the possibility of drug interactions and related adverse effects.
Pharmacist as a medical professional contributes to the optimization of chronic pharmacotherapy by exerting control over interactive potentials of individual drugs and via providing information service focused on drug adverse effects.